Methyltetrazine-PEG12-acid is a tetrazine-functionalized PEG linker facilitating rapid inverse-electron-demand Diels-Alder click chemistry for efficient and stable payload conjugation in antibody-drug conjugates. Keywords: ADC linker, methyltetrazine linker, PEG spacer, click chemistry, payload delivery.
Structure of
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Methyltetrazine-PEG12-acid is a pivotal component in the realm of chemical biology, particularly due to its application in the innovative field of click chemistry. The tetrazine moiety at its core is renowned for its ultra-fast reactivity with strained alkenes such as trans-cyclooctenes (TCO), forming a stable covalent bond through an inverse electron-demand Diels-Alder reaction. This specific and efficient click chemistry process is conducted under mild, bioorthogonal conditions, meaning it can occur in the presence of other functional groups without interfering with biological systems. This makes Methyltetrazine-PEG12-acid an ideal reagent for labeling biomolecules such as proteins, nucleic acids, and small molecules, greatly facilitating the study of complex biological pathways and interactions in real-time.
In drug discovery and development, Methyltetrazine-PEG12-acid is instrumental in the formation of antibody-drug conjugates (ADCs). ADCs represent a class of therapeutics that combine the specific targeting capabilities of monoclonal antibodies with the potent cytotoxic effects of small-molecule drugs. The PEG12 spacer in Methyltetrazine-PEG12-acid provides a flexible linker, enhancing the solubility and pharmacokinetic properties of these conjugates. By precisely attaching drugs to antibodies through click chemistry, this reagent makes it possible to deliver therapeutic agents selectively to cancer cells, thereby minimizing systemic toxicity and improving therapeutic outcomes. Such specificity in targeting enhances the efficacy and safety profiles of these bioconjugates, pushing the boundaries of precision medicine.
Methyltetrazine-PEG12-acid is also extensively used in the development of diagnostic imaging agents. The ability to form stable conjugates with imaging probes allows for precise visualization of biological processes and disease states. When linked to radiolabeled or fluorescent tags, the tetrazine-PEG12 conjugate can specifically bind to target molecules in vivo, providing high-resolution images that are essential for early disease detection, monitoring of disease progression, and evaluation of therapeutic responses. This capability is particularly crucial in the imaging of cancer and cardiovascular diseases, where precise localization and characterization of the disease site can significantly influence treatment strategies.
The versatility of Methyltetrazine-PEG12-acid extends further to the creation of functional biomaterials and nanoassemblies. Its PEG12 linker not only enhances solubility and biocompatibility but also facilitates the modification of surfaces and polymers with bioactive molecules through click chemistry. This ability is pivotal in tissue engineering, where creating bioactive surfaces can promote cell adhesion, growth, and differentiation. Additionally, in nanotechnology, Methyltetrazine-PEG12-acid enables the functionalization of nanoparticles with targeting ligands or therapeutic agents, enhancing their delivery capabilities and offering innovative approaches to tackle challenging medical conditions. Overall, the diverse applications of Methyltetrazine-PEG12-acid underscore its significance as a versatile and essential tool in advancing both basic research and clinical applications.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-01542 | Methyltetrazine-PEG5-nhs ester | 1802907-92-1 | |
BADC-01885 | Methyltetrazine-PEG12-NHS ester | ||
BADC-01287 | Methyltetrazine-PEG4-aldehyde | ||
BADC-01288 | Methyltetrazine-PEG4-hydrazone-DBCO | ||
BADC-01289 | Methyltetrazine-PEG4-oxyamine | ||
BADC-01290 | Methyltetrazine-PEG4-SS-NHS ester | ||
BADC-01291 | Methyltetrazine-PEG4-SS-PEG4-methyltetrazine |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.